Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Chief Counsel Ralph Tyler Begins Tenure With A Focus On "The Jungle"

Executive Summary

When Ralph Tyler was named FDA's new chief counsel he put together a reading course to help prepare for the job. The first book he took up was Upton Sinclair's 1906 classic "The Jungle.

You may also be interested in...



FDA's Dickinson Named Acting Chief Counsel Following Tyler’s Departure

FDA has tapped Elizabeth Dickinson for acting chief counsel, effective Aug. 7. Dickinson is taking the post on an interim basis while the agency seeks a permanent successor to Ralph Tyler.

FDA's Dickinson Named Acting Chief Counsel Following Tyler’s Departure

FDA has tapped Elizabeth Dickinson for acting chief counsel, effective Aug. 7. Dickinson is taking the post on an interim basis while the agency seeks a permanent successor to Ralph Tyler.

Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill

Ralph Tyler is leaving FDA 18 months after taking the helm as the agency's chief counsel.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051887

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel